Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Cancer Treatment Monitoring Startup Techsomed Raises $2.6 Million
Error: Contact form not found.
by CTech Staff
Metastatic Melanoma cancer cells: Photo: National Institutes of Health via Wikicommons.
CTech – Medtech startup Techsomed Medical Technologies Ltd. has raised $2.6 million in a round led by Johnson & Johnson Innovation–JJDC Inc., the company announced Wednesday. SCREEN Holdings, AMIT-Alfred Mann Institute at Technion Israel Institute of Technology, NextLeap Ventures, and Axil Capital also participated.
Founded in 2012, Israel-based Techsomed develops an image analysis system that helps track tissue response to thermal ablation, the process of destroying tumors using extreme heat or cold. The company’s system integrates with standard ultrasound devices to track the response of the target tissue to heat during the process, and visually simulates the process’ effects over the next 24 hours to provide surgeons with better control and accuracy.
Techsomed intends to use the funding towards receiving regulatory approval in the US, the European Union and Japan.
